ESCMID eLibrary
Search results
Icon explanation
Icon explanation
close
Abstract
ePoster
Handout
Image
Journal Article
Presentation
Video
Webcast
Found 11 results
-
P2686
Evaluation of the Staphylococcus aureus Analysis "1928D" Pipeline to determine the epidemiological threshold using whole-genome sequence data
16 April 2019
Session: Molecular & genomic surveillance of Gram-positive cocci
Relevance:100% -
P1882
Oritavancin activity against Staphylococcus aureus clinical isolates causing serious infections in hospitalised patients in Europe (2017-2018)
15 April 2019
Session: In vitro activity of newer antibacterial agents
Relevance:100% -
P1883
Activity of tedizolid and comparators against Enterococcus spp. that include multidrug-resistant clinical isolates from European and US medical centres (2016-2018)
15 April 2019
Session: In vitro activity of newer antibacterial agents
Relevance:100% -
O0930
Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Gram-negative clinical isolates and evaluation of resistance mechanisms
24 April 2018
Session: New beta-lactam / beta-lactamase inhibitors: efficacy and resistance development
Relevance:100% -
P1807
Evaluation of tedizolid activity against Gram-positive clinical isolates causing pneumonia in Europe and surrounding areas (2014-2017)
23 April 2018
Session: Resistance in various Gram-positives
Relevance:100% -
P1806
Current in vitro analysis of tedizolid activity against Gram-positive clinical isolates causing bloodstream infections in Europe and surrounding areas (2014-2017)
23 April 2018
Session: Resistance in various Gram-positives
Relevance:100% -
P0606
Changes in serotype distribution and antimicrobial non-susceptibility in Streptococcus pneumoniae causing pneumonia in adults from four European countries following paediatric immunization with the 13-valent pneumococcal conjugate vaccine (PCV13)
22 April 2018
Session: Focus: S. pneumoniae
Relevance:100% -
P1502
Activity of tedizolid against Gram-positive clinical isolates causing infections in Europe and surrounding areas (2014-2016)
24 April 2017
Session: Epidemiology and in vitro susceptibility of coagulase-negative staphylococci
Relevance:100% -
P1356
Telavancin activity against a global collection of Staphylococcus aureus clinical isolates (2013-2015)
24 April 2017
Session: Drugs against Gram-positives - more data
Relevance:100% -
P0139
Updated Analysis of Oritavancin Activity against Gram-positive Clinical Isolates Responsible for Documented Skin and Skin Structure Infections in United States and European Hospitals (2014-2016)
22 April 2017
Session: MRSA and MSSA: epidemiology and resistance
Relevance:100%
Search narrowed by
-
Topics
-
Type of material
-
Time period
